{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:00:38Z","timestamp":1753891238359,"version":"3.41.2"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T00:00:00Z","timestamp":1680652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Malignant pleural mesothelioma (MPM) is a kind of pleural cancer characterized by low incidence but high invasiveness. There is heterogeneity in survival among patients with MPM. Inflammation-related and electrolyte laboratory variables were previously reported as potential predictors of survival. We evaluated the relationship between overall survival and pre-treatment biomarkers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>Patients diagnosed with MPM in Beijing Chaoyang Hospital for more than 10 years were screened for this study. All basic, clinical, radiologic and laboratory variables were collected. The COX univariable and multivariable analysis were used to explore prognostic related risk factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Ninety patients with MPM were included. The median follow-up of all patients was 57\u2009months [interquartile range (IQR): 27\u2013100\u2009months]. The median survival time was 24 months (IQR: 12\u201352\u2009months). Univariate survival analyses indicated that age, Eastern Cooperative Oncology Group Performance Status, treatment, erythrocyte sedimentation rate, calcium, lymphocyte, hemoglobin, platelet-to-lymphocyte ratio (PLR), and monocyte-to-white blood cell ratio (MWR) were significantly related to survival. Multivariable analysis demonstrated that age [hazard ratio (HR), 2.548; 95% confidence interval (CI) 1.145\u20135.666; <jats:italic>p<\/jats:italic>\u2009=\u20090.022], calcium (HR, 0.480; 95% CI 0.270\u20130.855; <jats:italic>p<\/jats:italic>\u2009=\u20090.013), PLR (HR, 2.152; 95% CI 1.163\u20133.981; <jats:italic>p<\/jats:italic>\u2009=\u20090.015), and MWR (HR, 3.360; 95% CI 1.830\u20136.170; <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001) might have a significant impact on the prognosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Calcium, MWR, and PLR might be related to the prognosis of MPM patients. Analyzing the relationship between the results of inflammation-related and electrolyte laboratory variables in peripheral blood and prognosis could help clinicians evaluate the situation of patients.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1099685","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T14:04:58Z","timestamp":1680703498000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic significance of inflammation-related and electrolyte laboratory variables in patients with malignant pleural mesothelioma"],"prefix":"10.3389","volume":"10","author":[{"given":"Yuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nrc.2017.42","article-title":"Novel insights into mesothelioma biology and implications for therapy","volume":"17","author":"Yap","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/s41467-019-09307-6","article-title":"Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications","volume":"10","author":"Blum","year":"2019","journal-title":"Nat Commun"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S2213-2600(15)00183-6.","article-title":"Individualised management of malignant pleural effusion","volume":"3","author":"Clive","year":"2015","journal-title":"Lancet Respir Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1349-7006.2011.02165.x.","article-title":"National survey of malignant mesothelioma and asbestos exposure in Japan","volume":"103","author":"Gemba","year":"2012","journal-title":"Cancer Sci"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"5480","DOI":"10.1200\/JCO.2008.18.8268.","article-title":"Malignant pleural mesothelioma after household exposure to asbestos","volume":"26","author":"Patel","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2217\/fon.09.136.","article-title":"Role of systemic inflammatory response in predicting survival in patients with primary operable cancer","volume":"6","author":"Roxburgh","year":"2010","journal-title":"Future Oncol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/JTO.0b013e31823f45c1.","article-title":"Inflammation-based prognostic indices in malignant pleural mesothelioma","volume":"7","author":"Pinato","year":"2012","journal-title":"J Thorac Oncol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3390\/cancers13040658","article-title":"Biomarkers for malignant pleural mesothelioma-a novel view on inflammation","volume":"13","author":"Vogl","year":"2021","journal-title":"Cancers (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1183\/16000617.0057-2021","article-title":"Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis","volume":"30","author":"Schillebeeckx","year":"2021","journal-title":"Eur Respir Rev"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.lungcan.2020.09.026.","article-title":"Characterization of the immune microenvironment in malignant pleural mesothelioma reveals prognostic subgroups of patients","volume":"150","author":"Fusco","year":"2020","journal-title":"Lung Cancer"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.jtho.2021.06.014.","article-title":"Mesothelioma risk score: a new prognostic pretreatment, clinical-molecular algorithm for malignant pleural mesothelioma","volume":"16","author":"Yeap","year":"2021","journal-title":"J Thorac Oncol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"5234","DOI":"10.1002\/cncr.26143.","article-title":"Circulating and tumor-infiltrating myeloid cells predict survival in human pleural mesothelioma","volume":"117","author":"Burt","year":"2011","journal-title":"Cancer"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1038\/bjc.2014.478.","article-title":"Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales","volume":"111","author":"Linton","year":"2014","journal-title":"Br J Cancer"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jtho.2015.10.003.","article-title":"Contemporary analysis of prognostic factors in patients with Unresectable malignant pleural mesothelioma","volume":"11","author":"Bille","year":"2016","journal-title":"J Thorac Oncol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.3978\/j.issn.2072-1439.2015.11.15","article-title":"Clinical role of a new prognostic score using platelet-to-lymphocyte ratio in patients with malignant pleural mesothelioma undergoing extrapleural pneumonectomy","volume":"7","author":"Tagawa","year":"2015","journal-title":"J Thorac Dis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s10654-021-00752-6","article-title":"Systemic inflammation markers and cancer incidence in the UK biobank","volume":"36","author":"Nost","year":"2021","journal-title":"Eur J Epidemiol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12943-016-0529-z","article-title":"KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma","volume":"15","author":"Cheng","year":"2016","journal-title":"Mol Cancer"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1038\/bjc.2013.504.","article-title":"Existing models, but not neutrophil-to-lymphocyte ratio, are prognostic in malignant mesothelioma","volume":"109","author":"Meniawy","year":"2013","journal-title":"Br J Cancer"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1111\/j.1582-4934.2012.01584.x.","article-title":"Epigallocatechin-3-gallate induces mesothelioma cell death via H2 O2 -dependent T-type Ca2+ channel opening","volume":"16","author":"Ranzato","year":"2012","journal-title":"J Cell Mol Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"7103915","DOI":"10.1155\/2019\/7103915.","article-title":"Significance of EGFR and PTEN expression and PLR and NLR for predicting the prognosis of epithelioid malignant peritoneal mesothelioma","volume":"2019","author":"Liang","year":"2019","journal-title":"Gastroenterol Res Pract"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1159\/000499677.","article-title":"The value of COX-2, NF-kappaB, and blood routine indexes in the prognosis of malignant peritoneal mesothelioma","volume":"42","author":"Yin","year":"2019","journal-title":"Oncol. Res. Treat."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1183\/09031936.06.00135305.","article-title":"Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses","volume":"27","author":"Hegmans","year":"2006","journal-title":"Eur Respir J"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e1261241","DOI":"10.1080\/2162402X.2016.1261241.","article-title":"Prognostic and predictive aspects of the tumor immune microenvironment and immune checkpoints in malignant pleural mesothelioma","volume":"6","author":"Marcq","year":"2017","journal-title":"Onco Targets Ther"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.humpath.2016.01.010.","article-title":"Immune biomarkers PD-1\/PD-L1 and TLR3 in malignant pleural mesotheliomas","volume":"52","author":"Combaz-Lair","year":"2016","journal-title":"Hum Pathol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/bjc.2017.269.","article-title":"Evaluating the effect of immune cells on the outcome of patients with mesothelioma","volume":"117","author":"Chee","year":"2017","journal-title":"Br J Cancer"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"4836","DOI":"10.1002\/cam4.3111.","article-title":"An integrative histopathologic clustering model based on immuno-matrix elements to predict the risk of death in malignant mesothelioma","volume":"9","author":"Balancin","year":"2020","journal-title":"Cancer Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s00262-019-02366-0.","article-title":"Peri-operative monocyte count is a marker of poor prognosis in gastric cancer: increased monocytes are a characteristic of myeloid-derived suppressor cells","volume":"68","author":"Urakawa","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.pan.2019.10.002.","article-title":"Peripheral blood monocyte counts are elevated in the pre-diagnostic phase of pancreatic cancer: a population based study","volume":"19","author":"de la Fuente","year":"2019","journal-title":"Pancreatology"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1186\/s12885-018-4909-1","article-title":"High postoperative monocyte indicates inferior Clinicopathological characteristics and worse prognosis in lung adenocarcinoma or squamous cell carcinoma after lobectomy","volume":"18","author":"Hai","year":"2018","journal-title":"BMC Cancer"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/pros.23398.","article-title":"Peripheral blood monocyte count reflecting tumor-infiltrating macrophages is a predictive factor of adverse pathology in radical prostatectomy specimens","volume":"77","author":"Hayashi","year":"2017","journal-title":"Prostate"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/JLB.4RI0818-311R.","article-title":"Monocyte heterogeneity and functions in cancer","volume":"106","author":"Olingy","year":"2019","journal-title":"J Leukoc Biol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10555-006-9001-7.","article-title":"Role of tumor-associated macrophages in tumor progression and invasion","volume":"25","author":"Mantovani","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40164-021-00252-z.","article-title":"Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies","volume":"10","author":"Zhu","year":"2021","journal-title":"Exp Hematol Oncol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.lungcan.2021.04.025.","article-title":"Malignant pleural mesothelioma: comparison of surgery-based trimodality therapy to medical therapy at two tertiary academic institutions","volume":"156","author":"Larose","year":"2021","journal-title":"Lung Cancer"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1097\/SLA.0000000000004306.","article-title":"Pleurectomy decortication in the treatment of malignant pleural mesothelioma: encouraging results and novel prognostic implications based on experience in 355 consecutive patients","volume":"275","author":"Lapidot","year":"2022","journal-title":"Ann Surg"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.chest.2021.05.063.","article-title":"The association between pleural fluid exposure and survival in pleural mesothelioma","volume":"160","author":"Asciak","year":"2021","journal-title":"Chest"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1080\/0284186X.2021.1876246.","article-title":"Clinical prognostic factors in pleural mesothelioma: best supportive care and anti-tumor treatments in a real-life setting","volume":"60","author":"Ringgaard Petersen","year":"2021","journal-title":"Acta Oncol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1099685\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T14:05:04Z","timestamp":1680703504000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1099685\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,5]]},"references-count":37,"alternative-id":["10.3389\/fmed.2023.1099685"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1099685","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2023,4,5]]},"article-number":"1099685"}}